Difference between revisions of "Team:Tel-Hai/Proof"

Line 1: Line 1:
−
{{Tel-Hai}}
+
<html><link rel="stylesheet" type="text/css" href="https://2016.igem.org/Template:Tel-Hai/CSS?action=raw&ctype=text/css" />
 +
<img id="topimg" src="https://static.igem.org/mediawiki/2016/8/8b/T--Tel-Hai--dna.jpg" />
 +
</html> {{Team:Tel-Hai/Header}} <html>
  
−
<html>
+
<h3>Demonstrating A Proof of Concept<h3>
 +
<div class="proof">
 +
<p class="lead">In order to explain our proof of concept, it's necessary to remind ourselves the main project goal: <strong>"Development of a novel and <span style="color: red;">efficient delivery-system</span> for gene editing technology in Cystic Fibrosis"</strong></p>
  
 +
<h4>Work Plan:</h4>
 +
<ol>
 +
  <li>BBa_K2061005 consist: B-subunit of the E. coli Heat-Labile Toxin (LTB), linker and short viral DNA binding domain (DBD) sequences, expression via pSB1C3 plasmid in E. coli.</li>
 +
  <li>Isolation of the new chimeric protein: LTB + DBD (LTBD).</li>
 +
  <li>LTBD binding to GFP plasmid.</li>
 +
  <li>LTBD + plasmid enter the cell when introduced to NCI-H1650 (human lung epithelial cells expressing ganglioside receptors on their plasma membrane).</li>
 +
</ol>
  
 +
<p><small>* LTBD complex was pre incubated with and plasmid tagged with Hoechst for identification.</p>
  
 +
<h4>Our Proof of Concept Goals:</h4>
 +
<p>LTBD binding, delivery and expression of GFP plasmid to NCI-H1650:
 +
<ol>
 +
  <li>LTBD bind GFP plasmid DNA</li>
 +
  <li>LTBD bind to ganglioside receptor</li>
 +
  <li>LTBD + GFP plasmid enter the cell via endocytosis</li>
 +
  <li>Plasmid go to the nucleus</li>
 +
  <li>GFP gene expression</li>
 +
</ol></p>
  
  
−
<div class="column full_size">
+
<div class="image-holder"><img src="/wiki/images/7/72/T--Tel-Hai--proof1.jpg" /></div>
−
 
+
<p><strong>Results:</strong>
−
 
+
  <ol>
−
<p>
+
    <li>LTBD stop DNA migration by binding to the plasmid.
−
iGEM teams are great at making things work! We value teams not only doing an incredible job with theoretical models and experiments, but also in taking the first steps to make their project real.  
+
      <div class="image-holder"><img src="/wiki/images/f/fc/T--Tel-Hai--proof2.jpg" /></div></li>
−
</p>
+
    <li>LTBD with marked with green FITC attaching to cell membrane
−
 
+
      <div class="image-holder"><img src="/wiki/images/a/a1/T--Tel-Hai--proof3.jpg" /></div></li>
−
 
+
    <li>LTBD in cell's cytosol</li>
−
<h4> What should we do for our proof of concept? </h4>
+
    <li>DNA in the nucleus
−
<p>  
+
      <div class="image-holder"><img src="/wiki/images/2/25/T--Tel-Hai--proof4.jpg" /></div></li>
−
You can assemble a device from BioBricks and show it works. You could build some equipment if you're competing for the hardware award. You can create a working model of your software for the software award. Please note that this not an exhaustive list of activities you can do to fulfill the gold medal criterion. As always, your aim is to impress the judges!
+
−
</p>
+
−
 
+
−
</div>
+
−
 
+
  
 +
<p><small>* We were unable to achieve the 5th goal due lack of time.</small></p>
  
 +
<p><strong>We want to thank Dr. Moshik Kutner-Cohen and Dr. Niv Bachnoff for guiding us to achieve all above.</strong></p>
 
</div>
 
</div>
  
−
</html>
+
</div></html>

Revision as of 12:02, 19 October 2016

iGEM Tel-Hai 2016

Demonstrating A Proof of Concept

In order to explain our proof of concept, it's necessary to remind ourselves the main project goal: "Development of a novel and efficient delivery-system for gene editing technology in Cystic Fibrosis"

Work Plan:

  1. BBa_K2061005 consist: B-subunit of the E. coli Heat-Labile Toxin (LTB), linker and short viral DNA binding domain (DBD) sequences, expression via pSB1C3 plasmid in E. coli.
  2. Isolation of the new chimeric protein: LTB + DBD (LTBD).
  3. LTBD binding to GFP plasmid.
  4. LTBD + plasmid enter the cell when introduced to NCI-H1650 (human lung epithelial cells expressing ganglioside receptors on their plasma membrane).

* LTBD complex was pre incubated with and plasmid tagged with Hoechst for identification.

Our Proof of Concept Goals:

LTBD binding, delivery and expression of GFP plasmid to NCI-H1650:

  1. LTBD bind GFP plasmid DNA
  2. LTBD bind to ganglioside receptor
  3. LTBD + GFP plasmid enter the cell via endocytosis
  4. Plasmid go to the nucleus
  5. GFP gene expression

Results:

  1. LTBD stop DNA migration by binding to the plasmid.
  2. LTBD with marked with green FITC attaching to cell membrane
  3. LTBD in cell's cytosol
  4. DNA in the nucleus

    5. * We were unable to achieve the 5th goal due lack of time.

    We want to thank Dr. Moshik Kutner-Cohen and Dr. Niv Bachnoff for guiding us to achieve all above.